Videos

Voice Actor Discusses the ‘Platinum Lining’ Behind His Throat Cancer Diagnosis

July 30th 2021

Rob Paulsen is the voice behind many beloved cartoon characters, but after receiving a cancer diagnosis, he discovered a whole new way to relate to others.

Precision Medicine and Clinical Trials

July 28th 2021

Online resources available to patients with lung or thyroid cancer who are considering participation in a clinical trial after undergoing comprehensive genomic profiling.

Biomarker Testing: Centralized Vs Local Labs

July 28th 2021

The pros and cons of conducting pathology assessments for comprehensive biomarker tests in central laboratories versus local laboratories.

Role of Combination Therapy in RCC Management

July 27th 2021

Dr Thomas E. Hutson comments on the rationale for using combination immune therapy, as well as a combination of immune therapy and an oral VEGF inhibitor for initial treatment of RCC.

Managing Adverse Events in RCC

July 27th 2021

Kidney cancer expert, Dr Thomas E. Hutson, shares insight on managing adverse events resulting from combination therapy in RCC.

Common Questions on Medical Marijuana

July 26th 2021

An expert discusses the most common reasons his patients ask him about medical marijuana.

Access to Molecular Testing in the Community

July 21st 2021

Current barriers that impact patient access to comprehensive biomarker testing in the community and efforts underway to help advocate for increased accessibility to molecular assays moving forward.

Becoming Informed About Comprehensive Genomic Profiling

July 21st 2021

Resources available to support patients and community oncologists who are interested in learning more and gaining access to comprehensive biomarker testing.

VaxEffect Test Can Determine Immune Response to COVID-19 Vaccination in Patients With Cancer

July 20th 2021

The vaccine immune response monitoring platform can identify weak responses in patients with cancer and help determine the potential need for a booster shot.

Treatment Selection for the Management of RCC

July 20th 2021

Thomas E. Hutson, DO, PharmD, discusses his approach to determining the optimal initial therapy for a patient with RCC.

Emerging Agents for the Treatment of RCC

July 20th 2021

Urologic oncology expert, Dr Thomas E. Hutson, reviews additional agents and clinical trials in the pipeline for the treatment of RCC.

Educated Patient® Webinar: Gastrointestinal Stromal Tumor (GIST)

July 14th 2021

View the full CURE® Educated Patient® Webinar: Gastrointestinal Stromal Tumor (GIST).

Waiting for Results and Processing Information From Biomarker Testing

July 14th 2021

Cancer patients, Deborah and George, reflect on their emotions while waiting to receive back results from biomarker testing and explain what it was like processing the information delivered by their test results as presented by their oncologists.

George Labonte: Concerns Upon a Diagnosis of Medullary Thyroid Cancer

July 14th 2021

George Labonte explains what it was like receiving a diagnosis of medullary thyroid cancer and describes his experience being recommended for biomarker testing and concerns surrounding testing for germline mutations.

Phase 3 CLEAR Trial in mRCC

July 13th 2021

An expert in kidney cancer reviews the phase 3 CLEAR trial for frontline metastatic renal cell carcinoma.

Recent Advances in RCC Treatment

July 13th 2021

Dr Thomas E. Hutson shares insight on recent advances for the treatment of RCC including the role of and VEGF inhibitors, immune therapy, and mTOR inhibitors.

How Do You Get Back to a ‘Normal Life’ After Cancer?

July 9th 2021

Do you keep your job? Your friends? One cancer survivor discusses her decisions after being told her non-Hodgkin lymphoma was in remission.

Understanding Treatment Options in Melanoma

July 9th 2021

On behalf of AiM at Melanoma, Drs. Jeffrey Farma and Sunandana Chandra discuss current and future treatment options for melanoma, including a rare subtype.

Uveal Melanoma

July 9th 2021

The basics of uveal melanoma

Emerging Therapies in the Treatment of Melanoma

July 9th 2021

Discussing emerging therapies in melanoma

Immune-Modulating Antibodies for Melanoma Treatment

July 9th 2021

Understanding Immune-Modulating Antibodies

Adjuvant and Neoadjuvant Therapy in Melanoma

July 9th 2021

Updates in adjuvant and neoadjuvant therapy in melanoma

Patients Should Ask Their Providers About Clinical Trial Results

July 7th 2021

Results demonstrating the efficacy of Bavencio highlight the importance of incorporating recent clinical trial successes into the treatment conversation.

Receiving a Diagnosis of Advanced NSCLC

July 7th 2021

Deborah Kimmel describes the symptoms that led to a diagnosis of advanced non–small cell lung cancer and explains her journey to connecting with Dr Benjamin Levy and undergoing molecular testing.

Rationale for Molecular Testing in Real-World Scenarios

July 7th 2021

The rationale for testing 2 patients with cancer, Deborah and George, with molecular testing prior to managing their cases with novel therapy.

Goals of Therapy for RCC

July 6th 2021

Thomas E. Hutson, DO, PharmD, discusses the historic and current goals of therapy for the treatment of RCC.

Approaching Treatment for RCC

July 6th 2021

Kidney cancer expert, Dr Thomas E. Hutson, comments on treatment approaches for the management of renal cell carcinoma.

Treatment Challenges of laBCC

July 6th 2021

Anna C. Pavlick, D.O., describes the various challenges health care providers may face when treating patients with locally advanced basal cell carcinoma (laBCC).

laBCC: Cemiplimab Safety Monitoring

July 6th 2021

Insights into cemiplimab treatment monitoring and management in locally advanced basal cell carcinoma (laBCC).

Cemiplimab for Treatment of laBCC

July 6th 2021

An expert discusses treatment options available for patients with locally advanced basal cell carcinoma (laBCC) who don’t respond or are intolerant to the first-line therapy option.